- 1、本文档共22页,可阅读全部内容。
- 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
- 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载。
- 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
查看更多
Radio piperacillin sodium - sulbactam sodium (4-1) Pharmacokinetic Study
PAGE \* MERGEFORMAT 22
Radio piperacillin sodium / sulbactam sodium (4:1) Pharmacokinetic Study
Author: Weimin Ji Zhang Huilin SUN Pei-hong ZHAO Cai-yun Zhou Zhao Xia Zhao Dongfang Liu Yuwang
【Abstract】 Objective To compare intravenous infusion of piperacillin / sulbactam (4:1) compound formulations in healthy volunteers the pharmacokinetics. Methods 10 healthy volunteers were randomly cross intravenous infusion of piperacillin / sulbactam (2000mg/500mg) compound preparation, piperacillin (2000mg), sulbactam (500mg), were determined by RP-HPLC serum and urine drug concentrations of piperacillin and sulbactam. The results in the body of piperacillin and sulbactam plasma concentration - time curves can be a two-compartment model best fit. The obtained pharmacokinetic parameters were: right individual piperacillin and piperacillin / sulbactam in the piperacillin cmax = (124.40 ± 20.19) and (138.70 ± 25.53) mg / L; elimination half-life t1 / 2 were (0.80 ± 0.16) h and (0.88 ± 0.39) h; drug - when the area under the curve AUC 0 - ∞ were (129.23 ± 32.91) and (155.81 ± 58.52) mg * h / L; 12h urinary recovery rate of , respectively (55.4 ± 22.0)% and (43.6 ± 12.3)%. Sulbactam and piperacillin / sulbactam in the peak sulbactam concentration c max, respectively (27.50 ± 3.22) and (35.10 ± 4.68) g / L, drug - when the area under the curve AUC 0 - ∞ were ( 29.25 ± 4.99) and (44.37 ± 6.48) mg * h / L; elimination half-life t 1 / 2, respectively (1.03 ± 0.24) h and (1.02 ± 0.15) h; 12h urine recoveries were (51.8 ± 25.6) % and (41.5 ± 19.4)%. Conclusion subjects of the three kinds of preparation in the 30min infusion were well tolerated in vivo disposition of sulbactam to piperacillin no significant effect, but the disposition of piperacillin on sulbactam significantly affect the body. Of piperacillin and sulbactam in compound preparation of the urine excretion rate is less than when the individual excretion rate of administration, suggesting that competitive
您可能关注的文档
- Qingshan District Baotou City Inner Mongolia hepatitis B virus infection in preschool children in Investigation and Analysis.doc
- Qingtiankui patterns of genetic diversity of.doc
- Qingwen Baidu decoction on mumps meningitis treatment experience.doc
- Qingyitang Efficacy of treatment of acute pancreatitis.doc
- Qingyitang Efficacy of treatment of acute pancreatitis_0.doc
- Qingying cooling method in the application of prevention and treatment of diabetic complications.doc
- Qingyi positive side of pancreatic cancer CFPAC1 xenografts in nude mice and serum levels of interleukin 6 interleukin 8 and tumor necrosis factorin.doc
- Qinlian Extraction of anti-viral capsules.doc
- Qinling Mountain HCMV gN genotype distribution and its relationship with intrauterine infection.doc
- Qipai brand when it safe 'landing'-.doc
- 中国国家标准 GB 42125.11-2025测量、控制和实验室用电气设备的安全要求 第11部分:用于处理医用材料的灭菌器和清洗消毒器的特殊要求.pdf
- 《GB 42125.11-2025测量、控制和实验室用电气设备的安全要求 第11部分:用于处理医用材料的灭菌器和清洗消毒器的特殊要求》.pdf
- 《GB/T 15237-2025术语工作及术语科学 词汇》.pdf
- GB/T 15237-2025术语工作及术语科学 词汇.pdf
- GB/T 22454-2025企业建模与体系结构 企业建模构件.pdf
- 中国国家标准 GB/T 15237-2025术语工作及术语科学 词汇.pdf
- 中国国家标准 GB/T 22454-2025企业建模与体系结构 企业建模构件.pdf
- 《GB/T 22454-2025企业建模与体系结构 企业建模构件》.pdf
- 中国国家标准 GB/T 18910.64-2025液晶显示器件 第6-4部分:测试方法 带动态背光的液晶显示模块.pdf
- 《GB/T 18910.64-2025液晶显示器件 第6-4部分:测试方法 带动态背光的液晶显示模块》.pdf
文档评论(0)